Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural killer cells in multiple sclerosis: A review
Max Mimpen, Joost Smolders, Raymond Hupperts, et al.
Immunology Letters (2020) Vol. 222, pp. 1-11
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

NK Cells in Autoimmune Diseases: Protective or Pathogenic?
Meifang Liu, Shujuan Liang, Cai Zhang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 76
Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry
Wenzhe Yi, Ping Xiao, Xiaochen Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 68
Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
Agata Matejuk, Arthur A. Vandenbark, Halina Offner
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 58
In Situ Activated NK Cell as Bio‐Orthogonal Targeted Live‐Cell Nanocarrier Augmented Solid Tumor Immunotherapy
Dandan Meng, Hong Pan, Wei He, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 29
Closed Access | Times Cited: 39
The role of CD56bright NK cells in neurodegenerative disorders
Carla Rodriguez-Mogeda, Chaja M. J. van Ansenwoude, Lennart van der Molen, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis
Sujan Kumar Sarkar, Annie M. L. Willson, Margaret A. Jordan
Journal of Immunology Research (2024) Vol. 2024, pp. 1-31
Open Access | Times Cited: 9
The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
Caterina Veroni, Francesca Aloisi
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis
Marina Rode von Essen, R. Hansen, Camilla Kaae Højgaard, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 4
Open Access | Times Cited: 34
Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis
Sabela Rodríguez‐Lorenzo, Lynn van Olst, Carla Rodriguez-Mogeda, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 29
Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients
Mina Mohammadinasr, Soheila Montazersaheb, Vahid Hosseini, et al.
Cytokine (2024) Vol. 179, pp. 156624-156624
Open Access | Times Cited: 7
Natural Killer Cells in Multiple Sclerosis: Entering the Stage
Jarne Beliën, An Goris, Patrick Matthys
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
Alice Willison, Tobias Ruck, Georg Lenz, et al.
Journal of Neurology (2022) Vol. 269, Iss. 7, pp. 3937-3958
Open Access | Times Cited: 19
Engineered IL‐21‐Expressing Nanovesicles for Co‐Delivery of GOX and Ferrocene to Induce Synergistic Anti‐Tumor Effects
Chao Li, Mengyang Zhou, Li Yang, et al.
Advanced Healthcare Materials (2025)
Closed Access
The liminal space between hope and grief: The phenomenon of uncertainty as experienced by people living with relapsing-remitting multiple sclerosis
Eva van Reenen, Inge A. M. van Nistelrooij, Leo H. Visser, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0315501-e0315501
Open Access
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases
Jiewen Xie, Jie Wang, Xuejiao Cui
Autoimmunity Reviews (2025), pp. 103803-103803
Closed Access
Natural killer cells in multiple sclerosis: foe or friends?
Fatemeh Aghaee, Mohammadreza Abedinpour, Saeid Anvari, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
A Reaction-Diffusion Model for Relapsing-Remitting Multiple Sclerosis with a Treatment Term
Romina Travaglini
Lecture notes in computational science and engineering (2025), pp. 430-437
Closed Access
Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
Daniela Gallo, Eliana Piantanida, Matteo Gallazzi, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 31
<p>Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?</p>
Mena Al‐Ani, Noha Mousaad Elemam, Jennifer E. Hundt, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3243-3254
Open Access | Times Cited: 22
The IL-2 – IL-2 receptor pathway: Key to understanding multiple sclerosis
Daphne Peerlings, Max Mimpen, Jan Damoiseaux
Journal of Translational Autoimmunity (2021) Vol. 4, pp. 100123-100123
Open Access | Times Cited: 17
Progress in Mechanism of Astragalus membranaceus and Its Chemical Constituents on Multiple Sclerosis
Yong Peng, Xiang Deng, Shanshan Yang, et al.
Chinese Journal of Integrative Medicine (2022) Vol. 29, Iss. 1, pp. 89-95
Closed Access | Times Cited: 12
The ratio of circulating CD56dim NK cells to follicular T helper cells as a promising predictor for disease activity of relapsing-remitting multiple sclerosis
Jiaqi Ding, Yan Xu, Cong Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31533-e31533
Open Access | Times Cited: 2
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment
Daniela Gallo, Antonino Bruno, Matteo Gallazzi, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
Max Mimpen, Anne‐Hilde Muris, Linda Rolf, et al.
European Journal of Neurology (2020) Vol. 28, Iss. 3, pp. 901-909
Open Access | Times Cited: 15
Metabolic determinants of leukocyte pathogenicity in neurological diseases
Marah C. Runtsch, Giovanni Battista Ferrara, Stefano Angiari
Journal of Neurochemistry (2020) Vol. 158, Iss. 1, pp. 36-58
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top